saascode

Showcanon

A writers-room canon workspace linking scripts, approved facts, timelines, character states, draft changes, contradiction candidates and supervisor decisions.

Genesis score6.57/10
Make Showcanon real.0/500
500 more votes and Showcanon is authorized for build.
0%500 to authorize
Backing is the vote. When an idea crosses 500, we pull it into the build pipeline and ship it for real — the votes decide what gets built next, not an editor.
The case

Long-running productions accumulate character history, timelines, locations, props, relationships and intentional exceptions across scripts and revisions. The supplied research confirms three Western competitors covering show bibles, knowledge graphs and continuity assistance. The market is therefore partially filled; Showcanon's proposed difference is reviewable contradiction detection while a draft is being written.

Showcanon would preserve each source script, revision, scene and extracted assertion with a source span and confidence. Script supervisors or other authorized owners would promote assertions into a versioned canon with effective episode, timeline position, scope and notes. A draft change would be compared against that approved canon and explicit continuity rules to produce candidates, not errors.

A character may lie, forget, dream, time-travel or appear in a retcon. A contradiction may be intentional, unresolved or based on an extraction mistake. Deterministic rules only enforce constraints someone authored; they do not make the underlying canon true. Model confidence cannot substitute for showrunner or script-supervisor authority. Every dismissal and override should remain available so later drafts are not repeatedly flagged without context.

Unreleased scripts, cast details and production plans are confidential intellectual property. The product needs project isolation, narrow roles, retention controls, export, deletion and explicit policy for whether customer material may improve shared models. The buyer hypothesis is a showrunner, script supervisor or production-development leader, but production size, episode count, workflow authority, budget, union or employment constraints and current competitor need validation.

Who pays — and why

A showrunner, script supervisor or production-development leader responsible for maintaining an authorized show bible and reviewing continuity.

What it unlocks
A source-linked canon graph preserving script revision, scene, assertion, source span, confidence, owner approval, effective episode and correction
A draft-time continuity layer separating explicit policy, extracted fact, approved canon, proposed change, contradiction candidate and competing explanation
A review history for confirmed issue, intentional exception, retcon, unresolved question, dismissal, override and later supersession
How Genesis scored it
6.57across seven criteria
tension 8temporal 8blindspot 6buyer 8leverage 6convergence 5why-not 5
8
Productive tension

Immediate continuity prompts can reduce rework, while overconfident flags can flatten intentional ambiguity and creative change.

8
Temporal window

Active competitors and current model capabilities make draft-time assistance feasible now.

5
Why nobody did it

Canon extraction and creative exception handling explain difficulty, but competitors already build show bibles and graphs.

Why it scored well

The input defines a specific production role and confirms an active category while isolating a draft-time review workflow not evident in competitor descriptions.

What's holding it back

Three direct competitors, unverified related capabilities, confidential-data requirements, creative exceptions and buyer workflow adoption narrow the gap.

Signals detected3 sources crossed
SignalSupplied competitor research

SignalSupplied feature research

SignalSupplied feature comparison

Direction briefshowcanon.md
showcanon.md
Want this pointed at your vertical?Point Genesis at your own market and constraints — it invents adjacent, fork-ready ideas, private to you before they hit the public feed.

Discussion

?

No comments yet — be the first to weigh in.